Related Experiment Video
Updated: May 10, 2025
Seven Steps to Stellate Cells
Published on: May 10, 2011
HBV activates hepatic stellate cells through RUNX2/ITGBL1 axis
Fengchun Shi1, Wei Tan1, Wei Huang2
1Department of Infectious Diseases, Research Laboratory of Clinical Virology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Insights
RUNX2 drives liver fibrosis in chronic hepatitis B (CHB) by increasing integrin beta-like 1 (ITGBL1) expression. Targeting RUNX2 may offer a new therapy for CHB patients with liver fibrosis.
Area of Science:
- Hepatology
- Molecular Biology
- Fibrosis Research
Background:
- Chronic hepatitis B (CHB) is a global health concern, with liver fibrosis significantly impacting disease progression.
- Existing antiviral therapies do not always resolve liver fibrosis in CHB patients, necessitating new biomarkers and treatments.
- This study explores the molecular mechanisms of HBV-induced liver fibrosis, specifically the role of RUNX2 in regulating ITGBL1.
Purpose of the Study:
- To investigate the molecular mechanism of HBV-induced liver fibrosis.
- To determine the role of RUNX2 in regulating ITGBL1 expression in the context of HBV infection.
- To assess the therapeutic potential of targeting the RUNX2/ITGBL1 pathway.
Main Methods:
- Utilized in vitro hepatocyte models and an in vivo HBV mouse model.
- Employed chromatin immunoprecipitation (ChIP), luciferase reporter assays, and Western blotting to analyze RUNX2-ITGBL1 interactions.
- Evaluated the impact of RUNX2 inhibition (using Vitamin D3 and CADD522) on ITGBL1 expression and hepatic stellate cell activation.
Main Results:
- RUNX2 was found to directly bind the ITGBL1 promoter, increasing its expression and promoting hepatic stellate cell activation.
- HBV infection led to significant upregulation of both RUNX2 and ITGBL1 in liver cells.
- Inhibition of RUNX2 effectively reduced ITGBL1 levels and inhibited hepatic stellate cell activation, indicating the pathway's critical role.
Conclusions:
- RUNX2 promotes liver fibrosis in HBV-infected patients through the upregulation of ITGBL1.
- Targeting RUNX2 presents a promising therapeutic strategy for managing liver fibrosis in chronic hepatitis B.
Background:
Chronic hepatitis B (CHB) remains a global health challenge, with liver fibrosis serving as a critical determinant of disease progression. Despite antiviral treatments, liver fibrosis often persists in CHB patients, highlighting the need for additional biomarkers and therapeutic targets. This study investigates the molecular mechanism underlying HBV-induced liver fibrosis, focusing on the role of RUNX2 in regulating integrin beta-like 1 (ITGBL1), a key factor in fibrogenesis.
Methods:
We examined the relationship between RUNX2 and ITGBL1 in both in vitro hepatocyte models and an in vivo HBV mouse model. Using chromatin immunoprecipitation (ChIP), luciferase reporter assays, and Western blotting, we assessed RUNX2 binding to the ITGBL1 promoter and its impact on gene expression. We also evaluated the effects of RUNX2 inhibition using Vitamin D3 and CADD522 on ITGBL1 expression and hepatic stellate cell activation.
Results:
Our findings reveal that RUNX2 directly binds to the ITGBL1 promoter, enhancing its expression and promoting hepatic stellate cell activation. We show that HBV infection significantly upregulates both RUNX2 and ITGBL1 in liver cells. Inhibition of RUNX2 with Vitamin D3 or CADD522 significantly reduced ITGBL1 levels and blocked hepatic stellate cell activation. These results suggest that the RUNX2/ITGBL1 pathway is critical in the progression of liver fibrosis in HBV-infected patients.
Conclusions:
RUNX2 promotes liver fibrosis in HBV-infected patients by upregulating ITGBL1 expression. Our findings suggest that targeting RUNX2 could be a potential therapeutic approach to mitigate liver fibrosis in chronic hepatitis B.
Related Concept Videos
01:24Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
01:16TGF - β Signaling Pathway
01:19Multipotency of Hematopoietic Stem Cells
01:01Regulation of Hematopoietic Stem Cells
01:24T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:24B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...